CorMedix Inc. (FRA:19KA)
Germany · Delayed Price · Currency is EUR 8.20
+0.10 (1.23%)
Last updated: Dec 1, 2025, 8:10 AM CET
CorMedix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 214.3 | 43.47 | - | 0.07 | 0.19 | 0.24 | Upgrade | |
Revenue Growth (YoY) | 1647.67% | - | - | -65.74% | -20.19% | -15.54% | Upgrade |
Cost of Revenue | 12.2 | 3.19 | - | 0 | 0.15 | 0.2 | Upgrade |
Gross Profit | 202.1 | 40.28 | - | 0.06 | 0.04 | 0.03 | Upgrade |
Selling, General & Admin | 82.06 | 58.7 | 35.8 | 20.01 | 16.35 | 13.88 | Upgrade |
Research & Development | 12.46 | 3.94 | 13.16 | 10.68 | 13.13 | 13.38 | Upgrade |
Operating Expenses | 98.15 | 62.64 | 48.96 | 30.69 | 29.48 | 27.26 | Upgrade |
Operating Income | 103.95 | -22.36 | -48.96 | -30.62 | -29.44 | -27.22 | Upgrade |
Interest Expense | -0.97 | -0.04 | -0.03 | -0.03 | -0.02 | -0.03 | Upgrade |
Interest & Investment Income | 3.47 | 2.58 | 2.68 | 0.33 | 0.01 | 0.12 | Upgrade |
Currency Exchange Gain (Loss) | -0.12 | -0.03 | -0.03 | 0.04 | -0.02 | -0.06 | Upgrade |
Other Non Operating Income (Expenses) | 0.02 | 0.52 | - | - | - | - | Upgrade |
EBT Excluding Unusual Items | 106.34 | -19.32 | -46.34 | -30.29 | -29.46 | -27.2 | Upgrade |
Other Unusual Items | -2.4 | - | - | - | - | - | Upgrade |
Pretax Income | 107.03 | -19.32 | -46.34 | -30.29 | -29.46 | -27.2 | Upgrade |
Income Tax Expense | -55.47 | -1.39 | - | -0.59 | -1.25 | -5.17 | Upgrade |
Net Income | 162.5 | -17.93 | -46.34 | -29.7 | -28.21 | -22.03 | Upgrade |
Net Income to Common | 162.5 | -17.93 | -46.34 | -29.7 | -28.21 | -22.03 | Upgrade |
Shares Outstanding (Basic) | 68 | 59 | 51 | 40 | 38 | 29 | Upgrade |
Shares Outstanding (Diluted) | 72 | 59 | 51 | 40 | 38 | 29 | Upgrade |
Shares Change (YoY) | 24.69% | 15.65% | 26.39% | 6.93% | 31.87% | 18.26% | Upgrade |
EPS (Basic) | 2.40 | -0.30 | -0.91 | -0.74 | -0.75 | -0.77 | Upgrade |
EPS (Diluted) | 2.25 | -0.30 | -0.91 | -0.74 | -0.75 | -0.77 | Upgrade |
Free Cash Flow | 74.42 | -50.73 | -38.74 | -24.58 | -22.58 | -22.08 | Upgrade |
Free Cash Flow Per Share | 1.03 | -0.86 | -0.76 | -0.61 | -0.60 | -0.77 | Upgrade |
Gross Margin | 94.31% | 92.66% | - | 94.29% | 22.00% | 14.37% | Upgrade |
Operating Margin | 48.51% | -51.43% | - | -46819.91% | -15417.51% | -11378.44% | Upgrade |
Profit Margin | 75.83% | -41.24% | - | -45409.90% | -14774.70% | -9207.70% | Upgrade |
Free Cash Flow Margin | 34.73% | -116.70% | - | -37573.53% | -11826.24% | -9229.69% | Upgrade |
EBITDA | 108.2 | -22.05 | -48.89 | -30.54 | -29.38 | -27.09 | Upgrade |
EBITDA Margin | 50.49% | -50.71% | - | - | - | - | Upgrade |
D&A For EBITDA | 4.25 | 0.31 | 0.07 | 0.08 | 0.06 | 0.13 | Upgrade |
EBIT | 103.95 | -22.36 | -48.96 | -30.62 | -29.44 | -27.22 | Upgrade |
EBIT Margin | 48.51% | -51.43% | - | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.